Italy Pharmaceuticals and Healthcare Report Q4 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Curious about BaaS? Get the full feature comparison in our free eBook comparing the time to create your own cloud backend to a Backend as a Service like Kinvey. From our sponsors

Italy Pharmaceuticals and Healthcare Report Q4 2013 Sep 18th 2013, 00:00, by swapnil BMI View: While the implementation of cost-containment policies targeting the pharmaceutical industry in Italy may work to prevent the healthcare expenditure budget from overshooting, in the long term such policies may lower incentives for structural reform of the health care sector. This is because in theory they do not guarantee the efficient provision and management of healthcare services. The Italian public sector operates through regional autonomous communities, resulting in a decentralised approach to drug procurement and healthcare provision. Headline Expenditure Projections ? Pharmaceuticals: EUR21.99bn (US$27.93bn) in 2012 to EUR20.93bn (US$27.83bn) in 2013; -4.8% in local currency terms and -11.8% in … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=116104. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/italy-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions